Inicio / Noticias de Biosimilares / Why biosimilars are changing the pharmaceutical industry

Why biosimilars are changing the pharmaceutical industry

0 / 5 (0 votos)
Why biosimilars are changing the pharmaceutical industry

Why has Celltrion chosen to focus on biosimilars?

Celltrion has been devoted to provide quality medicines at a more affordable price to increase access to biologic treatments for patients through innovation. The efforts can be seen through the bearing of the fruits from biosimilar infliximab CT-P13’s (Remsima/Inflectra) successful launch in many countries around the world. Hence, we plan to not only make biosimilars but also intend to add value to medicines by developing biobetters and new medicines…

Seguir leyendo

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.